Financhill is a comprehensive financial analysis platform that provides stock analysis, market data, investment tools, and educational resources to help investors make informed decisions.

How do I get started with Financhill?

You can start by creating a free account, exploring our stock analysis tools, setting up a watchlist, or trying our 7-day trial for full access to all premium features.

What features does Financhill offer?

Financhill offers stock analysis, technical charts, fundamental data, earnings information, dividend tracking, portfolio management, market screening tools, and educational resources.

What are 10K annual reports?

10K reports are comprehensive annual reports filed by public companies with the SEC, containing detailed financial statements, business operations, risk factors, and management discussion.

How often are annual reports updated?

Annual reports are typically filed once per year, usually within 60-90 days after the company's fiscal year end. We update our database as soon as new reports become available.

How do I analyze NMTC stock?

Use our comprehensive analysis tools including technical charts, fundamental metrics, earnings data, and Stock Score to evaluate NMTC investment potential.

What is NMTC stock price today?

Get real-time NMTC stock price, historical data, and price charts on Financhill. Track NMTC performance with our advanced analysis tools.

Is NMTC a good investment?

Evaluate NMTC investment potential using our Stock Score, fundamental analysis, technical indicators, and earnings data. Consider your risk tolerance and investment goals.

How to buy NMTC stock?

To buy NMTC stock, open a brokerage account, research the company using our analysis tools, and place your order through your broker. Always do your own research before investing.

What is the market cap of NMTC?

View detailed market capitalization data and company valuation metrics for NMTC on our comprehensive analysis page.

What is the P/E ratio of NMTC?

Use our fundamental analysis tools to view NMTC P/E ratio and compare valuation metrics with industry peers.

What are NMTC earnings?

View NMTC earnings data, quarterly results, revenue growth, and profit margins on our comprehensive earnings analysis page. Track earnings trends and analyst estimates.

Back

NeuroOne Medical Technologies Corp. 10K Form

Buy

NMTC
NeuroOne Medical Technologies Corp.

Last Price:

$0.82

Seasonality Move:

-4.53%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2021-02-12	10K	NMTC/NeuroOne Medical Technologies Corp. Annual
2021-01-28	10K	NMTC/NeuroOne Medical Technologies Corp. Annual
2020-12-09	10K	NMTC/NeuroOne Medical Technologies Corp. Annual
2020-08-13	10Q	NMTC/NeuroOne Medical Technologies Corp. Quarterly
2020-05-14	10Q	NMTC/NeuroOne Medical Technologies Corp. Quarterly
2020-02-14	10Q	NMTC/NeuroOne Medical Technologies Corp. Quarterly

Receive NMTC News And Ratings

See the #1 stock for the next 7 days that we like better than NMTC

NMTC Financial Statistics

Sales & Book Value

Annual Sales:	$12.1M
Cash Flow:	$-1.5M
Price / Cash Flow:	0
Annual Sales:	$0.14
Price / Book:	5.23

Profitability

EPS (TTM):	-0.07850
Net Income (TTM):	$-3.6M
Gross Margin:	$8.1M
Return on Equity:	-89.54%
Return on Assets:	-47.53%

NeuroOne Medical Technologies Corp. Earnings Forecast

Key NeuroOne Medical Technologies Corp. Financial Ratios

The Gross Profit Margin over the past 16 years for NMTC is 67.30%.
The Selling, General & Administrative Expenses for NMTC have been equal to 61.04% of Gross Profit Margin.
The Research & Development expenses have been 41.19% of Revenue.
The Net Earning history of NMTC is -29.80% of Total Revenues.
Per Share Earnings over the last 16 years have been positive in 7 years.

NeuroOne Medical Technologies Corp. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange:	NASDAQ
Industry:	Health Care Equipment & Supplies
Sector:	Health Care
Current Symbol:	NMTC
Website:	nmtc1.com

Debt

Debt-to-Equity Ratio:	0.04
Current Ratio:	4.43
Quick Ratio:	3.4

Price-to-Earnings

Trailing P/E Ratio:	0
Forward P/E Ratio:	0

NMTC Technical Analysis vs Fundamental Analysis

Buy

NeuroOne Medical Technologies Corp. (NMTC) is a Buy

Is NeuroOne Medical Technologies Corp. a Buy or a Sell?

NeuroOne Medical Technologies Corp. stock is rated a Buy

The current NeuroOne Medical Technologies Corp. [NMTC] share price is $0.73. The Score for NMTC is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.